Delayed-type hypersensitivity reactions to nominal protein antigens and to environmental allergens: Similarities and differences

European Journal of Dermatology

Volumn 9, Issue 4, 1999, Pages 261-268

  Tsicopoulos, Anne ^a   Fahy, Olivier ^a   Tonnel, André Bernard ^a  

^a INSERM   (France)

Author keywords

Allergen; Delayed type hypersensitivity; Late phase reaction; Tuberculin

Indexed keywords

ALLERGEN; ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHLORDANE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TUBERCULIN;

ALLERGIC REACTION; ANTIGEN PRESENTING CELL; CELL INFILTRATION; DELAYED HYPERSENSITIVITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAST CELL; REVIEW; SKIN INFLAMMATION; T LYMPHOCYTE SUBPOPULATION;

ALLERGENS; ANIMALS; ANTIGEN-PRESENTING CELLS; CHEMOKINES; CYTOKINES; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; MAST CELLS; SKIN TESTS; T-LYMPHOCYTES; TUBERCULIN;

EID: 0032974639     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Coombs RRA, Gell PGH. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Coombs RRA, Gell PGH, eds. Clinical aspects of immunology. Oxford: Blackwell Scientific publications, 1968: 575.
2. DeShazo RD, Levinson AI, Dvorak HF. The late phase skin reaction: paradigm or epiphenomena? Ann Allergy 1983; 51: 166-72.
3. Kaplan G, Nusrat A, Witmer MD, Nath I, Cohn ZA, Distribution and turnover of Langerhans cells during delayed immune responses in human skin. J Exp Med 1987; 165: 763-76.
4. Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 1995; 155: 4207-17.
5. Gaga M, Frew AJ, Varney V, Kay AB. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase reactions and classical delayed-type hypersensitivity in man. J Immunol 1991; 147: 816-22.
6. Scheynius A, Klareskog L, Forsum U. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Clin Exp Immunol 1982; 49: 325-30.
7. Bergholtz BO, Thorsby E. HLA-D restriction of the macrophage-dependent response of immune human T lymphocytes to PPD in vitro: inhibition by anti-HLA-DR antisera. Scand J Immunol 1978; 8: 63-73.
8. Vyakarnam A, Lachmann PJ. Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus transformed B cell lines as requirement for antigen-presenting cells. Immunology 1984; 53: 601-10.
9. + T cells in murine contact hypersensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990; 144: 4121-8.
10. Viraben R, Aquilana C, Cambon L, Bazex J, Allergic contact dermatitis in HIV-positive patients. Contact Dermatitis 1994; 31: 326-7.
11. Suzumura Y, Ohasi M. Immunoelectron microscopic localization of HLA-DR antigen on mast cells and vessels in normal and tuberculin-reactive skin. Am J Dermatopathol 1991; 13: 568-74.
12. Love KS, Lakshmanan RR, Butterfield JH, Fox CC. IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1. Cell Immunol 1996; 170: 85-90.
13. Fox CC, Jewell SD, Whitacre CC. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol 1994; 158: 253-64.
14. Marchal G, Seman M, Milon G, Truffa-Bachi P, Zilberfarb V. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J Immunol 1982; 129: 954-8.
15. Lombardi G, Piccolella E, Vismara D, Colizzi V, Asherson GL. Candida albicans polysaccharide extract (MPPS) and PPD stimulate the productionn of interleukin-1 and lymphocyte proliferation. Clin Exp Immunol 1984; 58: 581-6.
16. +), in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol 1992; 148: 2058-61.
17. Wangoo A, Cook HT, Taylor GM, Shaw RJ. Enhanced expression of type 1 procollagen and transforming growth factor-beta in tuberculin-induced delayed type hypersensitivity. J Clin Pathol 1995; 48: 339-45.
18. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC, Modlin RL. Overexpression of I1L-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995; 154: 1956-63.
19. Robinson DS, Tsicopoulos A, Meng Q, Durham SR, Kay AB, Hamid Q. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol 1996; 14: 113-7.
20. Li L, Elliott JF, Mosmann TR IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 1994; 153: 3967-78.
21. Kaplan G, Luster AD, Hancock G, Cohn ZA. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med 1987; 166: 1098-108.
22. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-34.
23. Devergne O, Marfaing-Koda A, Schall TJ, Leger-Ravet MB, Sadick M, Peuchmaur M, Crevon MC, Kim KJ, Galanaud P, Emilie D. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994; 179: 1689-94.
24. Larsen CG, Thomsen MK, Gesser B, Thomsen PD, Deleuran BW, Nowak J, Skodt V, Thomsen HK, Deleuran M, Thestrup-Pedersen K, Harada A, Matsushima K, Menné T. The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J Immunol 1995; 155: 2151-7.
25. Rand ML, Warren JS, Mansour MK, Newman W, Ringler DJ. Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1. Am J Pathol 1996; 148: 855-64.
26. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV, Broxmeyer HE, Charo IF. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997; 100: 2552-61.
27. Norris P, Poston RN, Thaoms DS, Thornhill M, Hawk J, Haskard DO. The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delayed hypesensitivity. J Invest Dermatol 1991; 96: 763-70.
28. State ND, Justen JM, Sly LM, Beaudet AL, Bullard DC. Inhibition of delayed-type contact hypersensitivity in mice deficient in both E-selectin and P-selectin. Blood 1996; 88: 2973-9.
29. Tipping PG, Huang XR, Berndt MC, Holdsworth SR. P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity. Eur J Immunol 1996; 26: 454-60.
30. Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, Renz H, Hallmann R, Schefffold A, Radbruch A, Hamann A. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997; 385: 81-3.
31. Blackley CH. Experimental researches on the causes and nature of catarrhus aestivus (hay fever or hay asthma). London: Tindall and Cox, 1873:77.
32. Dolovich J, Hargreave FE, Chalmers R, Shier KJ, Gauldie J, Bienenstock J. Late allergic cutaneous responses in isolated IgE-dependent reactions. J Allergy Clin Immunol 1973; 52: 38-46.
33. Talbot SF, Atkins PC, Valenzono M, Zweiman B. Correlations of in vivo mediator release with late cutaneous allergic responses in humans. J Allergy Clin Immunol 1984; 74: 819-26.
34. Pienkowski MM, Adkinson NF, Plaut M, Norman PS, Lichtenstein LM. Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses. J Allergy Clin Immunol 1988; 82: 95-100.
35. Atkins PC, Schwartz LB, Adkinson NF, Von Allmen C, Valenzano M, Zweiman B. In vivo aAntigen-induced cutaneous mediator release: simultaneous comparisons of histamine, tryptase and prostaglandin D2 release and the effect of oral corticosteroid administration. J Allergy Clin Immunol 1990; 86: 360-70.
36. Massey W, Friedman B, Kato M, Cooper P, Kagey-Sobotka A, Lichtenstein LM, Schleimer RP. Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites. J Immunol 1993; 150: 1084-92.
37. Hogaboam C, Kunkel SL, Strieter RM, Taub DD, Lincoln P, Standiford TJ, Lukacs NW. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J Immunol 1998; 160: 6166-71.
38. Yano K, Yamagushi M, de Mora F, Lantz CS, Butterfield JH, Costa JJ, Galli SJ. Production of macrophage inflammatory protein-1 alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE binding ability. Lab Invest 1997; 77: 185-93.
39. Rajakulasingam K, Hamid Q, O'Brian F, Shotman E, Jose PJ, Williams TJ, Jacobson M, Barkans J, Durham SR. RANTES in human allergen-induced rhinitis: cellular source and relation to tissue eosinophilia. Am J Respir Crit Care Med 1997; 155: 696-703.
40. Ying S, Taborda-Barata L, Meng Q, Grant JA, Barkans J, Durham SR, Kay AB. High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans cells in allergen-induced late cutoeneous reactions in atopic subjects. Immunology 1998; 93: 281-8.
41. + lymphocytes, activated eosinophils and the magnitude of the allergen-induced late phase skin reaction in man. J Immunol 1988; 141: 4158-64.
42. Kon OM, Sihra BS, Compton CH, Leonard TB, Kay AB, Barnes NC. Randomised dose ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. Lancet 1998; 352: 1109-13.
43. + T cell clones. J Immunol 1992; 148: 738-45.
44. Dudler T, Altmann F, Carballido JM, Blaser K. Carbohydrate-dependent, HLA class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients. Eur J Immunol 1995; 25: 538-42.
45. Kay AB, Ying S, Varney V, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q. Messenger RNA expression of the cytokine gene cluster, IL-3, IL-4, IL-5, and GM-CSF in allergen-induced late-phase reactions in atopic subjects. J Exp Med 1991; 173: 775-8.
46. Ying S, Taborda-Barata L, Meng Q, Humbert M, Kay AB. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med 1995; 181: 2153-9.
47. Zweiman B, Kaplan AP, Tong L, Moskowitz AR. Cytokine levels in inflammatory responses in developing late-phase allergic reactions in the skin. J Allergy Clin Immunol 1997; 100: 104-9.
48. Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepada EA, Allakhverdig Z, Ghaffar O, Rothenberg MD, Luster AD, Hamid Q. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997; 159: 4593-601.
49. Ying S, Robinson DS, Meng Q, Rottman J, Ringler DJ, Mackay CR, Daugherty BL, Springer MS, Durham SR, Williams TJ, Kay AB. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial and endothelial cells. Eur J Immunol 1997; 27: 3507-16.
50. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor by human T helper 2 cells. Science 1997; 277: 2005-2007.
51. Leung DYM, Pober JS, Cotran RS. Expression of endothelium-leukocyte adhesion molecule-1 in elicited late phase allergic reactions. J Clin Invest 1991; 87: 1805-9.
52. Tsicopoulos A, Hamid Q, Haczku A, Jacobson M, Durham SR, North J, Barkans J, Corrigan C, Meng Q, Moqbel R, Kay AB. Kinetics of cell infiltration and cytokine mRNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. J Allergy Clin Immunol 1994; 94: 764-72.
53. Shirakawa T, Enomoto T, Shimazy S, Hopkin JM. The inverse association between tubeculin responses and atopic disorder. Science 1997; 275: 77-9.
54. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G. Infection with mice with mycobacterium bovis-Bacillus Calmette Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998; 187: 561-9.
55. Varney VA, Hamid QA, Gaga M, Sun Ying, Jacobson M, Frew AJ, Kay AB, Durham SR. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late?-phase cutaneous responses. J Clin Invest 1993; 92: 644-51.
56. Akoum H, Tsicopous A, Vorng H, Wallaert B, Dessaint JP, Joseph M, Hamid Q, Tonnel AB. Venom immunotherapy modulates IL-4 and IFN-γ m RNA expression of peripheral T lymphocytes. Immunology 1996; 87: 593-8.
57. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154: 4194-7.
58. O'Hehir RE, Yssel H, Verma S, De Vries JE, Spits H, Lamb JR. Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy. Int Immunol 1991; 3: 819-26.
59. Tsicopoulos A, Pestel J, Fahy O, Vorng H, Vandenbusche F, Porte H, Eraldi L, Wurtz A, Akoum H, Hamid Q, Wallaert B, Tonnel AB. Tuberculin-induced delayed type hypersensitivity in a model of hu-PBMC-SCID mice grafted with autologous skin. Am J Pathol 1998; 152: 1681-8.